Mutations in MFN2 have been recently disclosed in familial multisystemic disorder with optic atrophy beginning in early childhood, associated with axonal neuropathy and mitochondrial myopathy in adult life, a presentation resembling OPA1 plus phenotype. This evidence concerns the gene OPA1 and optic atrophy.